Distribution and Regulation of Interleukin 1-β Converting Enzyme in Rat and Man
Brain inflammation plays a role in neurodegenerative diseases such as multiple sclerosis1 and Alzheimer’s disease (AD).2 Indeed, anti-inflammatory agents have been proposed as therapy for AD.3 The most prominent cytokine mediating inflammation is interleukin-1β (IL-1β).4 IL-1β is a product of microglia5 (the brain’s resident macrophage), and activated microglia are found in neuritic plaques in AD.6 Furthermore, IL-1β is known to stimulate the production of amyloid precursor protein,7 amyloid being a major constituent of the neuritic plaque.
KeywordsDown Syndrome Quinolinic Acid Neuritic Plaque Monocytic Cell Line Multiple Antigenic Peptide
Unable to display preview. Download preview PDF.
- 1.L. Steinman, Autoimmune disease, Sci. Am. September: 107 (1993).Google Scholar
- 11.B.D. Shivers, D.A. Giegel, and K.M. Keane, Molecular cloning of rat interleukin-lß-converting enzyme: distribution and regulation, J. Cell. Biochem. Supplement 17B:119 (1993). (accepted for Cytokine) Google Scholar
- 18.Preparation and analysis of RNA in: “Current Protocols in Molecular Biology,” F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith and K. Stuhl, eds., Greene and Wiley Interscience, Brooklyn, NY, 1993.Google Scholar